
Drew Moghanaki/uclahealth.org and Henning Willers/giving.massgeneral.org
Sep 8, 2025, 16:37
Drew Moghanaki: Four Randomized Trials of SBRT and Immunotherapy in Stage I NSCLC
Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“A colorful slide and a pontificating Henning Willers to ponder the four randomized clinical trials evaluating SBRT + immunotherapy for stage I NSCLC.”
More posts featuring Drew Moghanaki.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 16:24
Sep 8, 2025, 15:59
Sep 8, 2025, 15:58